Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia.
J Nanobiotechnology. 2021 Oct 30;19(1):351. doi: 10.1186/s12951-021-01096-9.
Multi-modal therapy has attracted increasing attention as it provides enhanced effectiveness and potential stimulation of the immune community. However, low accumulation at the tumor sites and quick immune clearance of the anti-tumor agents are still insurmountable challenges. Hypothetically, cancer cell membrane (CCM) can homologously target the tumor whereas multi-modal therapy can complement the disadvantages of singular therapies. Meanwhile, moderate hyperthermia induced by photothermal therapy can boost the cellular uptake of therapeutic agents by cancer cells.
CCM-cloaked indocyanine green (ICG)-incorporated and abraxane (PTX-BSA)-loaded layered double hydroxide (LDH) nanosheets (LIPC NSs) were fabricated for target efficient photo-chemotherapy of colorectal carcinoma (CRC). The CCM-cloaked LDH delivery system showed efficient homologous targeting and cytotoxicity, which was further enhanced under laser irradiation to synergize CRC apoptosis. On the other hand, CCM-cloaking remarkably reduced the uptake of LDH NSs by HEK 293T cells and macrophages, implying mitigation of the side effects and the immune clearance, respectively. In vivo data further exhibited that LIPC NSs enhanced the drug accumulation in tumor tissues and significantly retarded tumor progression under laser irradiation at very low therapeutic doses (1.2 and 0.6 mg/kg of ICG and PTX-BSA), without observed side effects on other organs.
This research has demonstrated that targeting delivery efficiency and immune-escaping ability of LIPC NSs are tremendously enhanced by CCM cloaking for efficient tumor accumulation and in situ generated hyperthermia boosts the uptake of LIPC NSs by cancer cells, a potential effective way to improve the multi-modal cancer therapy.
多模态治疗因其能提高疗效和潜在刺激免疫群体而受到越来越多的关注。然而,抗肿瘤药物在肿瘤部位的蓄积低和快速的免疫清除仍然是难以克服的挑战。理论上,癌细胞膜(CCM)可以同源靶向肿瘤,而多模态治疗可以弥补单一疗法的缺点。同时,光热疗法引起的适度热疗可以增强癌细胞对治疗剂的细胞摄取。
制备了包被有癌细胞膜的吲哚菁绿(ICG)和载紫杉醇白蛋白(PTX-BSA)的层状双氢氧化物(LDH)纳米片(LIPC NSs),用于靶向治疗结直肠癌(CRC)的高效光化疗。CCM 包被的 LDH 递药系统表现出高效的同源靶向和细胞毒性,在激光照射下进一步增强,以协同促进 CRC 细胞凋亡。另一方面,CCM 包被显著降低了 LDH NSs 在 HEK 293T 细胞和巨噬细胞中的摄取,分别暗示减轻了副作用和免疫清除。体内数据进一步表明,LIPC NSs 在非常低的治疗剂量(ICG 和 PTX-BSA 分别为 1.2 和 0.6mg/kg)下,通过激光照射增强了药物在肿瘤组织中的积累,并显著延缓了肿瘤的进展,而对其他器官没有观察到副作用。
本研究表明,通过 CCM 包被,LIPC NSs 的靶向递药效率和免疫逃逸能力得到了极大的提高,有利于药物在肿瘤部位的蓄积,而原位产生的热疗可以增强癌细胞对 LIPC NSs 的摄取,这是一种提高多模态癌症治疗效果的潜在有效方法。